Sage Journals: Discover world-class research

Retricted access

Research article

First published 2004-06

Low-Dose-Rate Irradiation by 131 I Versus High-Dose-Rate External-Beam Irradiation in the Rat Pancreatic Tumor Cell Line CA20948

Suzanne Verwijnen, Astrid Capello, Bert Bernard [...]

Cancer Biotherapy and Radiopharmaceuticals

Retricted access

Research article

First published 2007-02

Radiobiology of Systemic Radiation Therapy

David Murray, Alexander J. McEwan

Cancer Biotherapy and Radiopharmaceuticals

Retricted access

Research article

First published 2004-06

A Theoretical Radiobiological Assessment of the Influence of Radionuclide Half-Life on Tumor Response in Targeted Radiotherapy When a Constant Kidney Toxicity Is Maintained

Wassim Abou-Jaoudé, Roger Dale

Cancer Biotherapy and Radiopharmaceuticals

Retricted access

Research article

First published 2003-08

Early Effects of Low Dose-Rate Radiation on Cultured Tumor Cells

Jörgen Carlsson, Emma Håkansson, Veronika Eriksson [...]

Cancer Biotherapy and Radiopharmaceuticals

Retricted access

Research article

First published 2002-08

Correlation of Red Marrow Radiation Dosimetry with Myelotoxicity: Empirical Factors Influencing the Radiation-Induced Myelotoxicity of Radiolabeled Antibodies,Fragments and Peptides in Pre-Clinical and Clinical Settings

Thomas M. Behr, Martin Béhé, George Sgouros

Cancer Biotherapy and Radiopharmaceuticals

Retricted access

Research article

First published 2021-10

177 Lu-dotatate use in chronic kidney disease patients: A single center experience

Sandhya Manohar, Panagiotis Kompotiatis, Thorvardur R Halfdanarson [...]

Journal of Onco-Nephrology

Retricted access

Research article

First published 2020-08

Alpha-Particle Therapy for Multifocal Osteosarcoma: A Hypothesis

Janina Baranowska-Kortylewicz, John G. Sharp, Timothy R. McGuire [...]

Cancer Biotherapy and Radiopharmaceuticals

Retricted access

Research article

First published 2012-11

Renal and Hematological Toxicity in Patients of Neuroendocrine Tumors After Peptide Receptor Radionuclide Therapy with 177 Lu-DOTATATE

Santosh K. Gupta, Suhas Singla, Chandrasekhar Bal

Cancer Biotherapy and Radiopharmaceuticals

Search results